Back to Search
ERNST LENGYEL, MD
MD
Gynecologic Oncology Physician
NPI: 1447296306IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
036110536(IL)
CMS Specialties
PrimaryGYNECOLOGICAL ONCOLOGY
Education
OTHER
Class of 1992
Research & Publications (20)
The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer.
PMID 19643405·Fertil Steril·2010
4-observational
C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu.
PMID 15455388·Int J Cancer·2005
8-other
MMP-2 functions as an early response protein in ovarian cancer metastasis.
PMID 19221481·Cell Cycle·2009
7-preclinical
Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation.
PMID 19584084·Hum Mol Genet·2009
8-other
A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings.
PMID 18815565·Appl Immunohistochem Mol Morphol·2009
4-observational
Up-regulation of alpha5-integrin by E-cadherin loss in hypoxia and its key role in the migration of extravillous trophoblast cells during early implantation.
PMID 19497979·Endocrinology·2009
8-other
Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
PMID 18381440·Cancer Res·2008
7-preclinical
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.
PMID 18340378·J Clin Invest·2008
7-preclinical
A special key for unlocking the door to targeted therapies of breast cancer.
PMID 18836657·ScientificWorldJournal·2008
8-other
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
PMID 18381893·Genes Dev·2008
8-other
Reversible posterior leukoencephalopathy syndrome following intravenous paclitaxel and intraperitoneal cisplatin chemotherapy for fallopian tube cancer.
PMID 18554701·Gynecol Oncol·2008
5-case
Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer.
PMID 18823649·Gynecol Oncol·2008
8-other
Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta1-integrin on the cell surface.
PMID 18048360·J Biol Chem·2008
8-other
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.
PMID 17308108·Cancer Res·2007
7-preclinical
Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer.
PMID 17510314·Mol Cancer Res·2007
7-preclinical
Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum.
PMID 17546601·Int J Cancer·2007
8-other
Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue.
PMID 17593080·Histopathology·2007
8-other
Let-7 expression defines two differentiation stages of cancer.
PMID 17600087·Proc Natl Acad Sci U S A·2007
8-other
Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2.
PMID 17957144·Cell Cycle·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5841 S MARYLAND AVE
CHICAGO, IL 60637 - Phone
- (888) 824-0200
Quick Facts
- NPI
- 1447296306
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile